{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:45:54Z","timestamp":1775979954554,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1872,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.virol.2008.03.022","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T12:13:00Z","timestamp":1209471180000},"page":"112-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus"],"prefix":"10.1016","volume":"376","author":[{"given":"John B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald A.","family":"Capraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griffith D.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2008.03.022_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1084\/jem.147.3.844","article-title":"Lysis of oncornaviruses by human serum Isolation of the viral complement (C1) receptor and identification as p15E","volume":"147","author":"Bartholomew","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2008.03.022_bib2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.126.4.1562","article-title":"Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum","volume":"126","author":"Beebe","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2006.07.001","article-title":"Complement 3d: from molecular adjuvant to target of immune escape mechanisms","volume":"121","author":"Bergmann-Leitner","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2003.11.029","article-title":"The relevance of complement to virus biology","volume":"319","author":"Blue","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.03.022_bib5","series-title":"Fields Virology","first-page":"249","article-title":"Innate responses to viral infections","author":"Biron","year":"2007"},{"key":"10.1016\/j.virol.2008.03.022_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4049\/jimmunol.112.2.866","article-title":"Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes","volume":"112","author":"Cooper","year":"1974","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1084\/jem.144.4.970","article-title":"Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway","volume":"144","author":"Cooper","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2008.03.022_bib9","first-page":"663","article-title":"Scanning and transmission electron microscopic studies of complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts","volume":"100","author":"Daniels","year":"1980","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2008.03.022_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14760584.3.6.693","article-title":"Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease","volume":"3","author":"Delgado","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2008.03.022_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/iai.11.6.1235-1243.1975","article-title":"Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid","volume":"11","author":"Des Prez","year":"1975","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2008.03.022_bib12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1099\/vir.0.79880-0","article-title":"Cell surface activation of the alternative complement pathway by the fusion protein of measles virus","volume":"85","author":"Devaux","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2008.03.022_bib13","doi-asserted-by":"crossref","first-page":"11116","DOI":"10.1128\/JVI.01360-07","article-title":"Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses","volume":"81","author":"Dillon","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.03.022_bib14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.174.6.1417","article-title":"Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41","volume":"174","author":"Ebenbichler","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2008.03.022_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4049\/jimmunol.118.2.533","article-title":"Complement activation by measles virus cytotoxic antibodies: alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies","volume":"118","author":"Ehrnst","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib16","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/jvi.70.7.4253-4260.1996","article-title":"Immune evasion properties of herpes simplex virus type 1 glycoprotein gC","volume":"70","author":"Friedman","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.03.022_bib17","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.4049\/jimmunol.165.8.4528","article-title":"Novel mechanism of antibody-independent complement neutralization of Herpes Simplex virus type 1","volume":"165","author":"Friedman","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2249.2004.02616.x","article-title":"Mannan-binding lectin modulates the response to HSV-2 infection","volume":"138","author":"Gadjeva","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.molimm.2004.06.011","article-title":"Complement: a unique innate immune sensor for danger signals","volume":"41","author":"Gasque","year":"2004","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.virol.2008.03.022_bib20","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.72.12.5076","article-title":"On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes","volume":"72","author":"Hammer","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.virol.2008.03.022_bib21","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI116345","article-title":"Human mannose-binding protein functions as an opsonin for influenza A viruses","volume":"91","author":"Hartshorn","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virol.2008.03.022_bib22","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.124.5.2507","article-title":"The role of complement in viral infections III. Activation of the classical and alternative complement pathways by Sindbis virus","volume":"124","author":"Hirsch","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01315298","article-title":"Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity","volume":"87","author":"Hirsch","year":"1986","journal-title":"Arch. Virol."},{"issue":"10","key":"10.1016\/j.virol.2008.03.022_bib24","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.4049\/jimmunol.161.10.5712","article-title":"Human complement component C1q inhibits the infectivity of cell-free HTLV-I","volume":"161","author":"Ikeda","year":"1998","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2008.03.022_bib25","first-page":"229","article-title":"Cold activation of serum complement in patients with chronic hepatitis C: study on activating pathway and involvement of IgG","volume":"55","author":"Ishii","year":"2001","journal-title":"Acta Med. Okayama,"},{"issue":"7","key":"10.1016\/j.virol.2008.03.022_bib26","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.02128-06","article-title":"Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity","volume":"81","author":"Jayasekara","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.03.022_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.141.4.761","article-title":"Immunologic injury of cultured cells infected with measles virus. I. Role of IgG antibody and the alternative pathway","volume":"141","author":"Joseph","year":"1975","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.virol.2008.03.022_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1994","article-title":"T-cell regulation: with complements from innate immunity","volume":"7","author":"Kemper","year":"2007","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj1890173","article-title":"The human complement system: assembly of the classical pathway C3 convertase","volume":"189","author":"Kerr","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.virol.2008.03.022_bib30","unstructured":"Lamb, R.A., Parks, G.D., 2007. Paramyxoviridae: The viruses and their replication. In: Knipe, David, M., Howley, Peter, M., (Eds.), Fields Virology, Fifth Edition. Published by Wolters Kluwer and Lippincott Williams and Wilkins, pp. 1449\u20131496."},{"issue":"(507\u2013515","key":"10.1016\/j.virol.2008.03.022_bib31","article-title":"Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid","volume":"114","author":"McSharry","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.03.022_bib32","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.178.7.4489","article-title":"Factor H binding and function in sialylated pathogenic neisseiae is influenced by gonococcal, but not meningococcal, porin","volume":"178","author":"Madico","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2008.03.022_bib33","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20052388","article-title":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways","volume":"203","author":"Mehlhop","year":"2006","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.virol.2008.03.022_bib34","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.123.6.2518","article-title":"Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement\u2013dependent viral lysis","volume":"123","author":"Mills","year":"1979","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.virol.2008.03.022_bib35","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.4049\/jimmunol.140.11.3867","article-title":"Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350","volume":"140","author":"Mold","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib36","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1128\/JVI.02799-06","article-title":"Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease","volume":"81","author":"Morrison","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.03.022_bib37","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0264-410X(00)00392-3","article-title":"Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype","volume":"19","author":"Nojd","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.03.022_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.140.2.549","article-title":"Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement","volume":"140","author":"Oldstone","year":"1974","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2008.03.022_bib39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial C3 convertase of the alternative pathway: acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2008.03.022_bib40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1099\/0022-1317-83-5-1167","article-title":"High avidity cytotoxic T lymphocytes to a foreign antigen are efficiently activated following immunization with a recombinant paramyxovirus, simian virus 5","volume":"83","author":"Parks","year":"2002","journal-title":"J. Gen Virol"},{"key":"10.1016\/j.virol.2008.03.022_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2001.1298","article-title":"Controlled cell killing by a recombinant nonsegmented negative strand RNA virus","volume":"193","author":"Parks","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.03.022_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/viro.1995.1135","article-title":"Paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions","volume":"208","author":"Paterson","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.03.022_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin. Infec. Dis."},{"issue":"5","key":"10.1016\/j.virol.2008.03.022_bib44","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4049\/jimmunol.116.5.1431","article-title":"The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex","volume":"116","author":"Podack","year":"1976","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01729.x","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulation proteins factor 1 and factor H","volume":"63","author":"Reis","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2006.03.018","article-title":"Emerging patterns in complement-mediated pathogen recognition","volume":"125","author":"Roozendaal","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.virol.2008.03.022_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-065X.2001.1800103.x","article-title":"Structure and biology of complement C3, a connecting link between innate and acquired immunity","volume":"180","author":"Sahu","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virol.2008.03.022_bib48","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.4049\/jimmunol.160.11.5596","article-title":"Interaction of vaccinia virus complement control proteins: Factor I mediated degradation of C3b to iC3b inactivates the alternative complement pathway","volume":"160","author":"Sahu","year":"1998","journal-title":"J. Immunol.,"},{"issue":"5","key":"10.1016\/j.virol.2008.03.022_bib49","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.4049\/jimmunol.123.5.2144","article-title":"Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments","volume":"123","author":"Sissons","year":"1979","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2008.03.022_bib50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1073\/pnas.77.1.559","article-title":"Antibody-independent activation of the alternative complement pathway by measles virus-infected cells","volume":"77","author":"Sissons","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2008.03.022_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2006.12.005","article-title":"Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge","volume":"362","author":"Tompkins","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.03.022_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.1991.tb08115.x","article-title":"The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimeric anti-NIP antibodies with human Fc regions","volume":"84","author":"Valim","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib53","first-page":"433","article-title":"Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization","volume":"167","author":"Vasantha","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.03.022_bib54","first-page":"281","article-title":"Toward novel vaccines and therapies based on negative-strand RNA viruses","volume":"283","author":"Von Messling","year":"2004","journal-title":"Curr. Top Microbiol. Immunol."},{"issue":"20","key":"10.1016\/j.virol.2008.03.022_bib55","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1128\/JVI.76.20.10109-10121.2002","article-title":"Naturally occurring substitutions in the P\/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha\/beta interferon synthesis and cell death","volume":"76","author":"Wansley","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.03.022_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.118.1.348","article-title":"Host cell modification of Lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement","volume":"118","author":"Welsh","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2008.03.022_bib57","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.molimm.2007.06.149","article-title":"Complement evasion of pathogens: common strategies are shared by diverse organisms","volume":"44","author":"Zipfel","year":"2007","journal-title":"Mol. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220800192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220800192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:53:04Z","timestamp":1758585184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268220800192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S004268220800192X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2008.03.022","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2008.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}